Drug Shortage Report for MIDAZOLAM INJECTION
Report ID | 164282 |
Drug Identification Number | 02242904 |
Brand name | MIDAZOLAM INJECTION |
Common or Proper name | MIDAZOLAM INJECTION |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 5mL |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-07-04 |
Estimated end date | 2023-02-28 |
Actual end date | 2023-02-28 |
Shortage status | Resolved |
Updated date | 2023-03-01 |
Company comments | Fresenius Kabi Canada regrets to advise that due to production delays, our Midazolam Injection 1 mg/mL MD Vial 5 mL will be placed on allocation effective July 4, 2022. Contract customers will be allocated 100% of historical monthly demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-07-07 | English | Compare |
v2 | 2022-07-07 | French | Compare |
v3 | 2022-08-04 | English | Compare |
v4 | 2022-08-04 | French | Compare |
v5 | 2022-10-02 | English | Compare |
v6 | 2022-10-02 | French | Compare |
v7 | 2022-10-03 | English | Compare |
v8 | 2022-10-03 | French | Compare |
v9 | 2022-11-03 | English | Compare |
v10 | 2022-11-03 | French | Compare |
v11 | 2023-02-09 | English | Compare |
v12 | 2023-02-09 | French | Compare |
v13 | 2023-03-01 | English | Compare |
v14 | 2023-03-01 | French | Compare |
Showing 1 to 14 of 14